Suppr超能文献

神经退行性疾病相关蛋白的传播风险:实验已知和未知。

Risk of Transmissibility From Neurodegenerative Disease-Associated Proteins: Experimental Knowns and Unknowns.

机构信息

Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland.

Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia.

出版信息

J Neuropathol Exp Neurol. 2020 Nov 1;79(11):1141-1146. doi: 10.1093/jnen/nlaa109.

Abstract

Recent studies in animal models demonstrate that certain misfolded proteins associated with neurodegenerative diseases can support templated misfolding of cognate native proteins, to propagate across neural systems, and to therefore have some of the properties of classical prion diseases like Creutzfeldt-Jakob disease. The National Institute of Aging convened a meeting to discuss the implications of these observations for research priorities. A summary of the discussion is presented here, with a focus on limitations of current knowledge, highlighting areas that appear to require further investigation in order to guide scientific practice while minimizing potential exposure or risk in the laboratory setting. The committee concluded that, based on all currently available data, although neurodegenerative disease-associated aggregates of several different non-prion proteins can be propagated from humans to experimental animals, there is currently insufficient evidence to suggest more than a negligible risk, if any, of a direct infectious etiology for the human neurodegenerative disorders defined in part by these proteins. Given the importance of this question, the potential for noninvasive human transmission of proteopathic disorders is deserving of further investigation.

摘要

最近的动物模型研究表明,某些与神经退行性疾病相关的错误折叠蛋白可以支持同源天然蛋白的模板错误折叠,在神经系统中传播,因此具有经典朊病毒疾病(如克雅氏病)的一些特性。美国国家老龄化研究所召开了一次会议,讨论这些观察结果对研究重点的影响。这里介绍了讨论的概要,重点介绍了当前知识的局限性,突出了需要进一步研究的领域,以便在最小化实验室环境中潜在暴露或风险的同时指导科学实践。委员会得出结论,基于所有现有数据,尽管几种不同的非朊病毒蛋白与神经退行性疾病相关的聚集物可以从人类传播到实验动物,但目前没有足够的证据表明这些蛋白部分定义的人类神经退行性疾病存在直接传染性病因的风险,即使有,也是微不足道的。鉴于这个问题的重要性,具有神经病理特征的疾病的非侵入性人体传播的可能性值得进一步研究。

相似文献

1
Risk of Transmissibility From Neurodegenerative Disease-Associated Proteins: Experimental Knowns and Unknowns.
J Neuropathol Exp Neurol. 2020 Nov 1;79(11):1141-1146. doi: 10.1093/jnen/nlaa109.
3
Prion Diseases: A Unique Transmissible Agent or a Model for Neurodegenerative Diseases?
Biomolecules. 2021 Feb 2;11(2):207. doi: 10.3390/biom11020207.
5
Invited Review: The role of prion-like mechanisms in neurodegenerative diseases.
Neuropathol Appl Neurobiol. 2020 Oct;46(6):522-545. doi: 10.1111/nan.12592. Epub 2020 Feb 11.
6
Interaction between pathogenic proteins in neurodegenerative disorders.
J Cell Mol Med. 2012 Jun;16(6):1166-83. doi: 10.1111/j.1582-4934.2011.01507.x.
8
Proteopathic Strains and the Heterogeneity of Neurodegenerative Diseases.
Annu Rev Genet. 2016 Nov 23;50:329-346. doi: 10.1146/annurev-genet-120215-034943.
9
Prion-like mechanisms in the pathogenesis of tauopathies and synucleinopathies.
Curr Neurol Neurosci Rep. 2014 Nov;14(11):495. doi: 10.1007/s11910-014-0495-z.

引用本文的文献

2
Sensitive detection of pathological seeds of α-synuclein, tau and prion protein on solid surfaces.
PLoS Pathog. 2024 Apr 19;20(4):e1012175. doi: 10.1371/journal.ppat.1012175. eCollection 2024 Apr.
3
Conjugal Synucleinopathies: A Clinicopathologic Study.
Mov Disord. 2024 Jul;39(7):1212-1217. doi: 10.1002/mds.29783. Epub 2024 Apr 10.
4
Iatrogenic Alzheimer's disease in recipients of cadaveric pituitary-derived growth hormone.
Nat Med. 2024 Feb;30(2):394-402. doi: 10.1038/s41591-023-02729-2. Epub 2024 Jan 29.
5
Autoclave treatment fails to completely inactivate DLB alpha-synuclein seeding activity.
Biochem Biophys Rep. 2023 Mar 3;34:101446. doi: 10.1016/j.bbrep.2023.101446. eCollection 2023 Jul.
6
Aβ and tau prions feature in the neuropathogenesis of Down syndrome.
Proc Natl Acad Sci U S A. 2022 Nov 16;119(46):e2212954119. doi: 10.1073/pnas.2212954119. Epub 2022 Nov 7.
9
Pathogenic prion structures at high resolution.
PLoS Pathog. 2022 Jun 30;18(6):e1010594. doi: 10.1371/journal.ppat.1010594. eCollection 2022 Jun.
10
Isotope-labeled amyloid-β does not transmit to the brain in a prion-like manner after peripheral administration.
EMBO Rep. 2022 Jul 5;23(7):e54405. doi: 10.15252/embr.202154405. Epub 2022 May 27.

本文引用的文献

1
Potential human transmission of amyloid β pathology: surveillance and risks.
Lancet Neurol. 2020 Oct;19(10):872-878. doi: 10.1016/S1474-4422(20)30238-6. Epub 2020 Sep 16.
2
A single ultrasensitive assay for detection and discrimination of tau aggregates of Alzheimer and Pick diseases.
Acta Neuropathol Commun. 2020 Feb 22;8(1):22. doi: 10.1186/s40478-020-0887-z.
3
Novel tau filament fold in corticobasal degeneration.
Nature. 2020 Apr;580(7802):283-287. doi: 10.1038/s41586-020-2043-0. Epub 2020 Feb 12.
4
Discriminating α-synuclein strains in Parkinson's disease and multiple system atrophy.
Nature. 2020 Feb;578(7794):273-277. doi: 10.1038/s41586-020-1984-7. Epub 2020 Feb 5.
5
6
Kinetics of α-synuclein prions preceding neuropathological inclusions in multiple system atrophy.
PLoS Pathog. 2020 Feb 4;16(2):e1008222. doi: 10.1371/journal.ppat.1008222. eCollection 2020 Feb.
7
Human tau pathology transmits glial tau aggregates in the absence of neuronal tau.
J Exp Med. 2020 Feb 3;217(2). doi: 10.1084/jem.20190783.
8
In Vitro Conversion Assays Diagnostic for Neurodegenerative Proteinopathies.
J Appl Lab Med. 2020 Jan 1;5(1):142-157. doi: 10.1373/jalm.2019.029801.
9
Transmissibility versus Pathogenicity of Self-Propagating Protein Aggregates.
Viruses. 2019 Nov 9;11(11):1044. doi: 10.3390/v11111044.
10
Million-fold sensitivity enhancement in proteopathic seed amplification assays for biospecimens by Hofmeister ion comparisons.
Proc Natl Acad Sci U S A. 2019 Nov 12;116(46):23029-23039. doi: 10.1073/pnas.1909322116. Epub 2019 Oct 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验